PAR 2.50% 19.5¢ paradigm biopharmaceuticals limited..

Paradigm must have some MRI evidence that the subchondral bone...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 478 Posts.
    lightbulb Created with Sketch. 130
    Paradigm must have some MRI evidence that the subchondral bone marrow edema's have reduced if they are to make such a claim
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.